<- Go Home
NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Market Cap
$353.4M
Volume
90.5K
Cash and Equivalents
$15.4M
EBITDA
-$22.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$56.4M
Profit Margin
73.83%
52 Week High
$18.15
52 Week Low
$5.45
Dividend
N/A
Price / Book Value
35.89
Price / Earnings
-11.95
Price / Tangible Book Value
35.89
Enterprise Value
$370.1M
Enterprise Value / EBITDA
-18.44
Operating Income
-$23.1M
Return on Equity
214.55%
Return on Assets
-14.74
Cash and Short Term Investments
$56.8M
Debt
$73.5M
Equity
$9.8M
Revenue
$76.5M
Unlevered FCF
-$4.4M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium